Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients (2010)
- Authors:
- USP affiliated authors: KATAYAMA, MARIA LUCIA HIRATA - FM ; BRENTANI, MARIA MITZI - FM ; FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM
- Unidade: FM
- DOI: 10.1590/s0100-879x2010007500135
- Subjects: BIOMARCADORES; MARCADOR MOLECULAR; NEOPLASIAS MAMÁRIAS (QUIMIOTERAPIA); QUIMIOTERAPIA ADJUVANTE; GENES
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Medical and Biological Research
- ISSN: 0100-879X
- Volume/Número/Paginação/Ano: n. 43, n. 12, p. 1225-1231, 2010
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BARROS FILHO, M. C et al. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Brazilian Journal of Medical and Biological Research, n. 12, p. 1225-1231, 2010Tradução . . Disponível em: https://doi.org/10.1590/s0100-879x2010007500135. Acesso em: 23 jan. 2026. -
APA
Barros Filho, M. C., Katayama, M. L. H., Brentani, H., Abreu, A. P. S., Barbosa, E. M., Oliveira, C. T., et al. (2010). Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients. Brazilian Journal of Medical and Biological Research, ( 12), 1225-1231. doi:10.1590/s0100-879x2010007500135 -
NLM
Barros Filho MC, Katayama MLH, Brentani H, Abreu APS, Barbosa EM, Oliveira CT, Góes JCS, Brentani MM, Folgueira MAAK. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2010 ;( 12): 1225-1231.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1590/s0100-879x2010007500135 -
Vancouver
Barros Filho MC, Katayama MLH, Brentani H, Abreu APS, Barbosa EM, Oliveira CT, Góes JCS, Brentani MM, Folgueira MAAK. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancer patients [Internet]. Brazilian Journal of Medical and Biological Research. 2010 ;( 12): 1225-1231.[citado 2026 jan. 23 ] Available from: https://doi.org/10.1590/s0100-879x2010007500135 - Gene expression of residual breast cancer after primary chemotherapy based on doxorubicin
- Vitamin D system is altered in breast cancer patients
- Influence of malignant breast cancer cell on the gene expression of fibroblasts obtained from involved [FN(+)]or uninvolved [FN(-)] lymph nodes of breast cancer patient
- Transcriptional profile and response to neoadjuvant chemotherapy in breast cancer
- Human breast tumor slices: A model for identification of vitamin D regulated genes in the tumor microenvironment
- Expression of the mRNA of the vitamid D receptor in hippocampal formation of rats submitted to temporal lobe epilepsy induced by pilocarpine
- Antiproliferative effects of 1,25-dihydroxyvitamin D3 on breast cells: a mini review
- Expressão de caderinas e fator repressor em tumor de pacientes com câncer de mama na presença ou ausência de células malignas em medula óssea
- Breast Cancer Response to Doxorubicin in Cultured Tissue Slices from Cannis Familiaris
- Perfil de expressão gênica diferencialde fibroblastos originados de carcinoma mamários em relação a fibroblastos de linfonodos comprometidos por células cancerosas obtidas de pacientes com câncer
Informações sobre o DOI: 10.1590/s0100-879x2010007500135 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
